<ARTICLE> 5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb </LEGEND> <MULTIPLIER> 1000000 <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> Dec-31-1994 <PERIOD-END> Dec-31-1994<F1> <CASH> 1,642 <SECURITIES> 781 <RECEIVABLES> 2,120 <ALLOWANCES> 77 <INVENTORY> 1,397 <CURRENT-ASSETS> 6,710 <PP&E> 5,836 <DEPRECIATION> 2,170 <TOTAL-ASSETS> 12,910 <CURRENT-LIABILITIES> 4,274 <BONDS> 644 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 54 <OTHER-SE> 5,650 <TOTAL-LIABILITY-AND-EQUITY> 12,910 <SALES> 11,984 <TOTAL-REVENUES> 11,984 <CGS> 3,122 <TOTAL-COSTS> 3,122 <OTHER-EXPENSES> 2,475 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 68 <INCOME-PRETAX> 2,555 <INCOME-TAX> 713 <INCOME-CONTINUING> 1,842 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1,842 <EPS-PRIMARY> 3.62 <EPS-DILUTED> 3.60 <FN> <F1> Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. E-7-1